Sean R Tunis

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy
    Sean R Tunis
    Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore, MD 21244, USA
    JAMA 290:1624-32. 2003
  2. ncbi Access with evidence development: the US experience
    Penny E Mohr
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    Pharmacoeconomics 28:153-62. 2010
  3. ncbi Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
  4. ncbi Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
  5. ncbi A clinical research strategy to support shared decision making
    Sean R Tunis
    Centers for Medicare and Medicaid Services CMS, Baltimore, Maryland, USA
    Health Aff (Millwood) 24:180-4. 2005
  6. ncbi Medicare coverage of ICDs
    Mark B McClellan
    Center for Medicare and Medicaid Services, Baltimore, USA
    N Engl J Med 352:222-4. 2005
  7. ncbi Economic analysis in healthcare decisions
    Sean R Tunis
    Am J Manag Care 10:301-4. 2004
  8. ncbi Why Medicare has not established criteria for coverage decisions
    Sean R Tunis
    N Engl J Med 350:2196-8. 2004
  9. ncbi Coverage options for promising technologies: Medicare's 'coverage with evidence development'
    Sean R Tunis
    Center for Medical Technology Policy
    Health Aff (Millwood) 25:1218-30. 2006
  10. ncbi The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development
    Matthew J Lindsay
    Foley Hoag, LLP, 155 Seaport Blvd, Boston, MA 02210 2600, USA
    AJR Am J Roentgenol 188:1109-13. 2007

Collaborators

Detail Information

Publications12

  1. ncbi Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy
    Sean R Tunis
    Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore, MD 21244, USA
    JAMA 290:1624-32. 2003
    ..For these changes to occur, clinical and health policy decision makers will need to become more involved in all aspects of clinical research, including priority setting, infrastructure development, and funding...
  2. ncbi Access with evidence development: the US experience
    Penny E Mohr
    Center for Medical Technology Policy, Baltimore, Maryland 21202, USA
    Pharmacoeconomics 28:153-62. 2010
    ....
  3. ncbi Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, Baltimore, MD 21202, USA
    J Clin Oncol 30:4256-61. 2012
    ..Recent efforts are beginning to demonstrate the potential to build on the work invested in developing HTA reports to provide a roadmap toward these objectives...
  4. ncbi Comparative effectiveness research: Policy context, methods development and research infrastructure
    Sean R Tunis
    Center for Medical Technology Policy, World Trade Center Baltimore, 401 E Pratt St, Suite 631, Baltimore, MD 21201, USA
    Stat Med 29:1963-76. 2010
    ..The approach to addressing each of these issues should be informed by the understanding that the primary purpose of CER is to help health care decision makers make informed clinical and health policy decisions...
  5. ncbi A clinical research strategy to support shared decision making
    Sean R Tunis
    Centers for Medicare and Medicaid Services CMS, Baltimore, Maryland, USA
    Health Aff (Millwood) 24:180-4. 2005
    ..A more systematic effort to produce this evidence will entail establishing research priorities, improving research methods, expanding the research infrastructure, and engaging new funds...
  6. ncbi Medicare coverage of ICDs
    Mark B McClellan
    Center for Medicare and Medicaid Services, Baltimore, USA
    N Engl J Med 352:222-4. 2005
  7. ncbi Economic analysis in healthcare decisions
    Sean R Tunis
    Am J Manag Care 10:301-4. 2004
  8. ncbi Why Medicare has not established criteria for coverage decisions
    Sean R Tunis
    N Engl J Med 350:2196-8. 2004
  9. ncbi Coverage options for promising technologies: Medicare's 'coverage with evidence development'
    Sean R Tunis
    Center for Medical Technology Policy
    Health Aff (Millwood) 25:1218-30. 2006
    ....
  10. ncbi The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development
    Matthew J Lindsay
    Foley Hoag, LLP, 155 Seaport Blvd, Boston, MA 02210 2600, USA
    AJR Am J Roentgenol 188:1109-13. 2007
    ..By linking access to PET for virtually all Medicare beneficiaries to the collection of clinically valuable evidence, the NOPR represents the cutting edge of the CED approach...
  11. ncbi Coverage with evidence development: a very good beginning, but much to be done. Commentary to Hutton et al
    Sean R Tunis
    Centre for Medical Technology Policy, 524 2nd Street, San Francisco, California 94107, USA
    Int J Technol Assess Health Care 23:432-5. 2007
  12. ncbi Federal initiatives to support rapid learning about new technologies
    Sean R Tunis
    Center for Medical Technology Policy, San Francisco, CA, USA
    Health Aff (Millwood) 26:w140-9. 2007
    ..The value of these efforts will depend on coordination among individuals and institutions in the public and private sectors; clarity about focus, purpose, and priorities; and adequate and reliable long-term funding...